The Department for Business, Energy and Industrial Strategy (BEIS) is launching the Life Sciences Innovative Manufacturing Fund (LSIMF) to support businesses investing in manufacturing projects in the UK.
This £60m fund will provide capital grants for investments in the manufacture of human medicines (drug substance and drug product), medical diagnostics and MedTech products.
This could include manufacturing investments in:
Applicants who apply in 2022 and align with the fund’s objectives will be prioritised for due diligence based on their ability to defray1 project expenditure and submit a grant claim form by March 2023, relative to the other applicants. Projects unable to claim grant funding before March 2023 will not be disadvantaged but we may agree a longer timeline for you to submit your application.
Once the £60m has been allocated, the fund will close. Applicants are encouraged to apply early, to avoid missing out on funding.
Full details can be found, here.